Renaissance Capital logo

IGMS News

US IPO Weekly Recap: Health and tech shine as week’s 5 IPOs close Friday up 20% or more

DDOG

Five health and tech companies went public this week, and each finished the week up at least 20%. One SPAC also IPO'd. Three companies and one SPAC submitted initial filings. After weeks of nonstop news coverage, The We Company (WE) delayed its IPO to the...read more

Cancer biotech IGM Biosciences prices IPO within the range at $16

IGM Biosciences logo

IGM Biosciences, a Phase 1/preclinical immuno-oncology biotech developing engineered antibodies, raised $175 million by offering 10.9 million shares at $16, within the $15 to $17 range. Insiders had planned to purchase $100 million of the IPO (57% of the...read more

IGM Biosciences ups IPO share offering by 40% as insiders indicate on additional $50 million

IGM Biosciences logo

IGM Biosciences, a Phase 1/preclinical immuno-oncology biotech developing engineered antibodies, raised the proposed deal size for its upcoming IPO on Tuesday. The Mountain View, CA-based company now plans to raise $175 million by offering 10.9 million...read more

US IPO Week Ahead: Datadog chases $7 billion valuation in 5-IPO week

APTXU

Five IPOs and one SPAC plan to raise $1.7 billion in the week ahead. Rumors are swirling that The We Company (WE) will launch its long-awaited IPO.  Datadog (DDOG) will join the year's growing list of VC-backed...read more